Episode 156: Immune Thrombocytopenic Purpura Series, Pt 2- Relapsed/Refractory
About this episode
This episode discusses treatment options for patients with relapsed/refractory Immune Thrombocytopenic Purpura following initial steroid treatment.
This week, we move to the relapsed/refractory ITP setting, focusing on what options are available to patients after their initial treatment with steroids ± IVIg, which we discussed in Episode 155. If you have not done so already, definitely listen to that episode as we build on the topics discussed here today! Content: - What are options after steroids? - How to counsel patients on options? - Is there a correct way to sequence available options? ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Youtube
People in this episode
Host: The Fellow On Call
Topics covered
- Immune Thrombocytopenic Purpura
- relapsed ITP
- refractory ITP
- treatment options
- patient counseling
- treatment sequencing
Keywords
- Immune Thrombocytopenic Purpura
- ITP
- treatment options
- steroids
- IVIg
- patient counseling
- treatment sequencing
Mentioned in this episode
Organizations: Rouleaux University Medical Center
Books & works: Episode 155
More episodes of The Fellow on Call: The Heme/Onc Podcast
- Episode 157: Immune Thrombocytopenic Purpura Series, Pt 3- Challenging Scenarios in ITP
- Episode 155: Immune Thrombocytopenic Purpura Series, Pt 1- First Line Management
- Episode 154: Ask The Program Directors-The Do’s and Don'ts of Applying to Hematology Fellowship (Career Development Series)
- Episode 153: Myeloma Capstone, Pt 2 - MRD-Guided Therapy, Maintenance, and Relapsed/Refractory Sequencing
- Episode 152: Myeloma Capstone, Pt 1 - Smoldering Myeloma & Frontline Treatment in the Elderly
- Episode 151: Myeloma Series, Pt. 11 - Role of bispecific T-cell engagers for relapsed/refractory multiple myeloma (2026)
Explore listener stats, chart rankings, contacts and more on the The Fellow on Call: The Heme/Onc Podcast podcast page.